Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

Exclusion Criteria

• •1. Clinically significant bleeding from gastrointestinal or other site within the last 24 hours and requires 2 or more units of blood to maintain a stable hemoglobin level
• •2. Hemodynamically unstable or on vasopressor agents for blood pressure support (except for renal-dosed dopamine)
• •3. On acute or chronic hemodialysis or continuous renal replacement therapy (CRRT)
• •4. Pregnancy
• •5. Inability to obtain informed consent
• •6. Uncontrolled sepsis as defined by hemodynamic instability
• •7. Post-liver transplant
• •8. Fulminant hepatic failure
• •9. Irreversible brain damage as indicated by the neurologic examination and CT imaging
• •10. Endocarditis
• •11. Pulmonary edema
• •12. Massive aspiration pneumonia secondary to Hepatic Encephalopathy
• •13. Active alcohol consumption as determined by a positive blood ethanol level on enrollment/admission
• •14. Acute main portal vein thrombosis in patients with Hepatocellular Carcinoma